CLAZOSENTAN
Product
IDORSIA PHARMACEUTICALS US INC
Total Payments
$35,529
Transactions
19
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $35,529 | 19 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,500 | 7 | 60.5% |
| Travel and Lodging | $13,604 | 6 | 38.3% |
| Food and Beverage | $425.59 | 6 | 1.2% |
Top Doctors Receiving Payments for CLAZOSENTAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurological Surgery | Fresno, CA | $15,598 | 5 |
| , M.D | Specialist | San Francisco, CA | $9,008 | 4 |
| , MD | Vascular Neurology | Burlington, MA | $5,774 | 6 |
| , M.D | Neurocritical Care | Valhalla, NY | $3,150 | 2 |
| , MD | Neurological Surgery | Baltimore, MD | $1,400 | 1 |
| , MD | Neurological Surgery | Baltimore, MD | $600.00 | 1 |
Ad
Manufacturing Companies
- IDORSIA PHARMACEUTICALS US INC $35,529
Product Information
- Type Product
- Total Payments $35,529
- Total Doctors 6
- Transactions 19
About CLAZOSENTAN
CLAZOSENTAN is a product associated with $35,529 in payments to 6 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is IDORSIA PHARMACEUTICALS US INC.
Payment data is available from 2023 to 2023. In 2023, $35,529 was paid across 19 transactions to 6 doctors.
The most common payment nature for CLAZOSENTAN is "Consulting Fee" ($21,500, 60.5% of total).